A Comparison of the Early, Transitional and Modern Eras of Endovascular Aneurysm Repair (EVAR): Improved Results Reflect Device Evolution and Refined Patient Selection  by Tadros, Rami O. et al.
JOURNAL OF VASCULAR SURGERY
44S Abstracts May Supplement 2013Improved Results Reﬂect Device Evolution and
Reﬁned Patient Selection
Rami O. Tadros, Peter L. Faries, Sharif H. Ellozy, Rachel
Schrier, Sung yup Kim, Rajesh Malik, Ageliki G.
Vouyouka, Robert A. Lookstein, Michael L. Marin.
Vascular Surgery, The Mount Sinai Medical Center, New
York, NY
Objectives: There have been three eras in the develop-
ment of EVAR: physician-made and early industry devices,
intermediary commercial endografts, and modern sten-
tgrafts. This study analyzed the differences in outcomes
between these three groups.
Methods: From 1992-2012, 1290 patients under-
went elective EVAR. Fifteen different devices were used
during this time. The three eras were deﬁned as: Era1:
1992-96; Era2: 1997-2006; Era3: 2007-2012. Grafts
used in each era were: Era1: physician-made and EVT;
Era2: Talent, Aneurx, Excluder, Quantum LP, Zenith,
Vangaurd, PG AAA, Ancure, Endologix, and Teramed;
Era3: Talent, Aneurx, Endurant, Excluder, Zenith, and
Aptus.
Results: Mean age was 75.2 years and 85% were
men. First generation patients were higher surgical risk
(Mean Glasgow Aneurysm Scores: Era1 84.81 vs Era3:
79.95, P ¼ .048). Adjunctive procedures increased
from Era1 to Era3 (P ¼ .014). Procedure times (P <
.001), Blood loss (P ¼ .01), and Length of stay (P <
.001) have declined overtime. Major peri-operative
complications (Era1: 23%, Era2: 9.2%, and Era3: 4.5%;
P < .001) and AAA-related peri-operative mortality
(Era1: 17.6%, Era2: 2.3%, and Era3: 0.0%; P < .001)Fig.have decreased. Type 1 and 3 endoleaks (P ¼ .011)
and the need for reintervention (P < .001) have dimin-
ished. Median survival for all causes of death and
freedom from aneurysm-related mortality signiﬁcantly
improved (Fig).
Conclusions: EVAR has evolved over the last 20 years
resulting in an overall improvement in efﬁciency, outcomes
and procedural success.
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Objectives: To determine predictors of conversion
from percutaneous (PEVAR) to an open approach
(OEVAR) during groin access of endovascular aortic aneu-
rysm repair (EVAR).
